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Misinformation and lack of knowledge 
hinder cervical cancer prevention
To the Editor: Cervical cancer is the second most common 
cancer, with an age-standardised incidence rate of 30 per  
100 000 per year, and is the leading cause of cancer mortality 
among South African women.1 The National Department 
of Health (NDOH) national screening policy entitles every 
woman attending public sector services to 3 free Papanicolaou 
(Pap) smears in her lifetime at 10-year intervals, starting 
at the age of 30 years. Properly implemented, this policy 
could decrease the incidence of cervical cancer by more than 
50%. Community awareness is the key to achieving optimal 
coverage and participation in the screening programme.
The causative link between high-risk human papillomavirus 
(HPV) and cervical cancer has been established.2 HPV vaccine 
offers great potential for primary prevention of cervical cancer 
in South Africa. Two prophylactic vaccines, with a good 
safety profile and sustained efficacy after 5 years,3,4 have been 
licensed for use in South Africa but are not yet available in the 
public health sector. Secondary prevention of cervical cancer 
through Pap smears remains vitally important as all women 
will not be vaccinated, some cervical cancers are caused by 
HPV types not included in the current HPV vaccines, and the 
vaccines are not effective in women who already have HPV 
infection.
We conducted a qualitative study between February 2007 
and March 2008 that explored key challenges and opinions 
towards HPV vaccination introduction in South Africa in 
three diverse areas in the Western Cape province. Health care 
providers, policy makers and key policy influentials at national 
and provincial levels were interviewed, and focus group 
discussions were carried out with women aged 21 - 57 years 
who had children who would be eligible for the HPV vaccine.5 
Knowledge and perceptions on cervical cancer and prevention 
were also explored.
Women’s levels of knowledge and understanding of 
cervical cancer, the causative relationship between HPV and 
cervical cancer, and the purpose and preventive nature of Pap 
smears was poor. Many knew of the availability of cervical 
screening services but did not fully understand the purpose 
of Pap smears. Some associated Pap smears with ‘cleansing 
or scraping the womb’, after possible exposure to a sexually 
transmitted infection, after having been raped or, in other 
instances, to ensure fertility. Health care providers confirmed 
some of these beliefs.
Health care providers displayed differing levels of 
knowledge of the current cervical screening policy, the 
rationale for the policy, and the links between HPV and 
cervical cancer. Some providers were misinformed about the 
South African cervical screening policy.
Lack of knowledge of cervical cancer is a prime barrier to 
preventing cervical cancer.6 We need to develop and evaluate 
innovative strategies to raise awareness about cervical cancer 
and the importance of screening as a preventive measure. 
For successful screening programmes, health care providers 
must understand the rationale of policy and the causative 
relationship between HPV and cervical cancer, and be 
cognisant of community misconceptions and beliefs.
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Complaints against doctors
To the Editor: The ‘patients corner’ in the South African 
Medical Association website prominently displays the 
following:
COMPLAINTS AGAINST DOCTORS:
 The Health Professions Council of South Africa (HPCSA) 
investigates complaints against medical practitioners on 
behalf of the public.
Complaints must be lodged in writing to:
The Registrar 




or on their website: www.hpcsa.co.za.
Of course the HPCSA accepts complaints. So do litigation 
lawyers, medical aid societies, fraud lines, consumer columns 
and the South African Police Services. The South African 
Medical Association at branch level also has an established 
structure to deal with complaints.
What possible reason has SAMA to prompt complainants 
to ‘mainline’ to the HPCSA, knowing full well the time lags, 
complexities and costs of defending at HPCSA level, imposing 
(as it does) considerable duress upon SAMA’s members? 
The foundation principle in resolving a dispute is to attempt 
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resolution at the lowest level. If this fails at the level of the 
individual doctor, the next lowest level to attempt resolution 
would be within the doctors’ association, namely SAMA. Why, 
then, does SAMA not say this to enquiring laymen?
Perhaps SAMA also plans to advertise litigation lawyers on 






Knees, Comrades and sample size
To the Editor: We wish to raise concerns with regard to the 
study published by Hagemann et al. (‘Do knees survive the 
Comrades Marathon?’).1 The design of the study is purported 
to be a prospective study of 10 randomly selected participants. 
Closer reading shows the sampling to be that of a convenience 
sample in which participants volunteered for the study. 
No mention is made of how potential participants were 
approached or, later, how many patients were excluded from 
the study owing to pre-existing injury. This sampling technique 
is not statistically random and introduces serious selection 
bias. Factors such as age, weight or whether it was an uphill or 
downhill race are also not considered.
The second point of concern is the very small sample size 
used in this study. Small sample sizes in medical studies are 
often a result of necessity, but there are inherent dangers in 
making use of them. Over the 6-year period (1997 - 2002), there 
were over 90 000 entrants in the Comrades Marathon.2 Using 
an alpha value of 0.05 and a 95% confidence level, based on a 
population of 90 000 entrants, the recommended sample size 
is 383. A sample size of only 10 introduces a 30.99% margin of 
error. This study then becomes an example of a type II error 
where finding that there is no difference between the two 
groups is primarily a factor of the small sample size rather than 
a reflection of an actual lack of difference.
Owing to its methodology and sample size, it would be ill-
advised to draw any valid conclusions from this study. These 
data might have been better suited to use as a case series from 







Department of Public Health
University of KwaZulu-Natal
1.    Hagemann GJ, Rijke AM, Corr RD. Do knees survive the Comrades Marathon? S Afr Med J 
2008; 98: 873-876.
2.    http://results.comrades.com (accessed 1 December 2008).
Drs Hagemann, Rijke and Corr reply: We thank Drs Rodseth 
and Geddes for their comments on our study. They focus on 
two aspects of the study: (i) its design – specifically on how 
the participants were selected in this prospective study; and 
(ii) the small sample size, which would introduce a margin of 
error contravening the conclusion that there was no difference 
between the two groups.
The study was designed to determine the effect of ultra-
marathon running on the structures of the normal knee and 
any unknown pre-existing abnormalities of the knee. In 
selecting participants, knees that had previous surgery or 
documented injuries were excluded and, therefore, none were 
excluded later on the basis of any such pre-existing injury. 
No other qualifications (such as age, weight or gender) were 
considered as conditions for eligibility. As part of the recruiting 
protocol, all participants were volunteers. We disagree that this 
selection of knees is non-random or introduces a selection bias. 
We did not provide information on the specifics of the race as 
this is readily available.1
As is often the case with prospective MRI studies, the 
small sample size was the result of necessity. However, in 
designing this study, we purposely restricted our aims to 
avoid the dangers inherent to this small size by limiting the 
study to normal knees (including by necessity those with 
unknown abnormalities) and by only registering changes on 
follow-up scans. Specifically, we disagree with the view that 
383 participants would be required for this study to meet 
the conditions of alpha equal to 0.05 and a 95% confidence 
level, based on 90 000 entrants. Such numbers of participants 
would have to be recruited if the purpose of this study were 
a complete inventory of all injuries, new and pre-existing, 
collected and followed up over the course of the three 
sequential MRI studies. However, by limiting the aims of this 
study, we have been able to demonstrate convincingly that 
there was no difference between the two groups. Researchers 
of similar prospective MRI studies on the knees of runners 
(references 5, 6, 7, 10, 11) had enrolled between 5 and 10 
participants to arrive at their conclusions.
1.   http://results.comrades.com
